Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Thrombosis Research

• Publication date

  1988-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(88)90026-6PMID 3146821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal Antibodies to Human 54,000 Molecular Weight Plasminogen Activator Inhibitor from Fibrosarcoma Cells - Inhibitor Neutralization and One-Step Affinity Purification

  1986cited by this paper
• Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.

  1985cited by this paper
• Identification of a reversible inhibitor of plasminogen activators in blood plasma

  1985cited by this paper
• Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma

  1984cited by this paper
• Evidence for a rapid inhibitor to tissue plasminogen activator in plasma.

  1983cited by this paper
• Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.

  1983cited by this paper
• Kinetics of the Inhibition of Plasmin in Acidified Human Plasma

  1982cited by this paper
• A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma

  1982cited by this paper
• Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.

  1976cited by this paper

• Tissue-type plasminogen activator (t-PA) activity

  1999cites this paper
• Current concepts of coagulation and fibrinolysis.

  1998cites this paper
• The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.

  1997cites this paper
• Single Dose of Nandrolone Does Not Prevent Postoperative Fibrinolytic Shutdown

  1995cites this paper
• Euglobulin lysis time in fresh and stored samples.

  1994cites this paper
• Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAT-1): Conditions and therapeutic targets

  1994cites this paper
• Localization of Epitopes Recognized by Monoclonal Antibodies on Tissue-type and Urokinase-type Plasminogen Activators Using Recombinant Hybrid Enzymes

  1993cites this paper
• In Vitro Diagnosis of Fibrinolysis: Present Status and Desired Improvements

  1992cites this paper
• Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: Evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods

  1992cites this paper
• Grupo de trabajo de Leiden sobre fibrinolisis: Procedimientos de recogida y manipulación de sangre para la evaluación del activador del plasminógeno de tipo tisular (t-PA) y del inhibidor-l del activador del plasminógeno (PAM)* ,

  1992cites this paper
• Tissue-type plasminogen activator activity assay

  1992cites this paper
• Familial clustering of defective release of t‐PA

  1991cites this paper
• A novel principle for assessment of stimulated fibrinolysis.

  1991cites this paper
• Effects of Gemfibrozil on Lipids and Haemostasis after Myocardial Infarction

  1990cites this paper
• LEIDEN FIBRINOLYSIS WORKING PARTY: BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENT OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (t-PA) AND PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1).

  1990cites this paper
• Regular moderate wine consumption for five weeks increases plasma activity of the plasminogen activator inhibitor-1 (PAI-1) in healthy young volunteers

  1990cites this paper